Literature DB >> 9040739

Dose-dependent, central effects of botulinum neurotoxin type A: a pilot study in the alert behaving cat.

B Moreno-López1, A M Pastor, R R de la Cruz, J M Delgado-García.   

Abstract

We investigated, in alert behaving cats, the long-term effects of botulinum neurotoxin (BoNT) type A injected into the lateral rectus muscle of the eye. We studied orthodromic field potentials recorded in the injected muscle, eye movements, and the discharge characteristics of the innervating abducens motoneurons. Single BoNT injections at doses from 0.01 to 0.3 ng/kg reduced, or even completely eliminated, eye movements in the abducting direction for up to 2 months without affecting the motoneuron discharge profile that remained related to actual eye movements of the contralateral unparalyzed eye. This result indicates that abducens motoneurons were still under the influence of the ocular motor central control system regardless of their ineffective action on lateral rectus muscle fibers. We also conclude that paralysis per se is not enough to initiate axotomy-like neural responses in ocular motoneurons. The injection of BoNT at a dose of 3 ng/kg produced significant changes in the discharge pattern of abducens motoneurons lasting up to 3 months-the maximum time checked. This finding was probably due to retrograde and, perhaps, transneuronal effects of BoNT when injected in a high dose. The results give some indications of the maximum allowable dose that can be used without the induction of unwanted side effects in the motoneuronal pool innervating the injected muscle.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9040739     DOI: 10.1212/wnl.48.2.456

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

Review 1.  Botulinum toxin for pain.

Authors:  Roberto Casale; Valeria Tugnoli
Journal:  Drugs R D       Date:  2008

2.  Transynaptic Action of Botulinum Neurotoxin Type A at Central Cholinergic Boutons.

Authors:  Matteo Caleo; Matteo Spinelli; Francesca Colosimo; Ivica Matak; Ornella Rossetto; Zdravko Lackovic; Laura Restani
Journal:  J Neurosci       Date:  2018-10-12       Impact factor: 6.167

3.  Botulinum toxin treatment of extraocular muscles in rabbits results in increased myofiber remodeling.

Authors:  Irma Ugalde; Stephen P Christiansen; Linda K McLoon
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-11       Impact factor: 4.799

Review 4.  Central voice production and pathophysiology of spasmodic dysphonia.

Authors:  Niv Mor; Kristina Simonyan; Andrew Blitzer
Journal:  Laryngoscope       Date:  2017-05-23       Impact factor: 3.325

Review 5.  Spasmodic dysphonia: a laryngeal control disorder specific to speech.

Authors:  Christy L Ludlow
Journal:  J Neurosci       Date:  2011-01-19       Impact factor: 6.167

6.  Eye Movements But Not Vision Drive the Development of Palisade Endings.

Authors:  Genova Carrero-Rojas; Paula M Calvo; Thomas Lischka; Johannes Streicher; Rosa R de la Cruz; Angel M Pastor; Roland Blumer
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-10-03       Impact factor: 4.925

7.  [Long-term treatment of phantom- and stump pain with Botulinum toxin type A over 12 months. A first clinical observation].

Authors:  U Kern; C Martin; S Scheicher; H Müller
Journal:  Nervenarzt       Date:  2004-04       Impact factor: 1.214

8.  Botulinum toxin type A for the treatment of muscle contractures secondary to acute spinal cord injury in a young cat.

Authors:  Robert I McGeachan; Tobias Schwarz; Danièlle A Gunn-Moore; Katia Marioni-Henry
Journal:  JFMS Open Rep       Date:  2020-06-01

9.  Spinal Central Effects of Peripherally Applied Botulinum Neurotoxin A in Comparison between Its Subtypes A1 and A2.

Authors:  Hidetaka Koizumi; Satoshi Goto; Shinya Okita; Ryoma Morigaki; Norio Akaike; Yasushi Torii; Tetsuhiro Harakawa; Akihiro Ginnaga; Ryuji Kaji
Journal:  Front Neurol       Date:  2014-06-23       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.